学术探索
学术期刊
新闻热点
数据分析
智能评审

Class II transactivator: Mastering the art of major histocompatibility complex expression

被引：181
作者：
Harton, JA
Ting, JPY
机构：
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
来源：
MOLECULAR AND CELLULAR BIOLOGY | 2000年 / 20卷 / 17期
关键词：
D O I：
10.1128/MCB.20.17.6185-6194.2000
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：6185 / 6194
页数：10
相关论文
共 153 条
[81]   TRANSCRIPTIONAL REGULATION IN MAMMALIAN-CELLS BY SEQUENCE-SPECIFIC DNA-BINDING PROTEINS [J].
MITCHELL, PJ ;
TJIAN, R .
SCIENCE, 1989, 245 (4916) :371-378
[82]   Major histocompatibility class II HLA-DRα gene expression in thyrocytes:: Counter regulation by the class II transactivator and the thyroid Y box protein [J].
Montani, V ;
Taniguchi, S ;
Shong, MH ;
Suzuki, K ;
Ohmori, M ;
Giuliani, C ;
Napolitano, G ;
Saji, M ;
Fiorentino, B ;
Reimold, AM ;
Ting, JPY ;
Kohn, LD ;
Singer, DS .
ENDOCRINOLOGY, 1998, 139 (01) :280-289
[83]  
Mora C, 1999, J IMMUNOL, V162, P4576
[84]  
MORENO CS, 1995, J IMMUNOL, V155, P4313
[85]   CREB regulates MHC class II expression in a CIITA-dependent manner [J].
Moreno, CS ;
Beresford, GW ;
Louis-Plence, P ;
Morris, AC ;
Boss, JM .
IMMUNITY, 1999, 10 (02) :143-151
[86]   MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression [J].
Morris, AC ;
Riley, JL ;
Fleming, WH ;
Boss, JM .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1998, 40 (06) :385-394
[87]   Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA [J].
MuhlethalerMOttet, A ;
Otten, LA ;
Steimle, V ;
Mach, B .
EMBO JOURNAL, 1997, 16 (10) :2851-2860
[88]   RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency [J].
Nagarajan, UM ;
Louis-Plence, P ;
DeSandro, A ;
Nilsen, R ;
Bushey, A ;
Boss, JM .
IMMUNITY, 1999, 10 (02) :153-162
[89]  
Nandan D, 1997, J IMMUNOL, V158, P1095
[90]  
NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493
45678910111213